Uncover Opportunities, Mitigate Risks
Market Insights
The German healthcare market is highly attractive, strategically important, and also: complex. We provide the vital insights for the right strategic and operational decisions.
Uncover Opportunities, Mitigate Risks
The German healthcare market is highly attractive, strategically important, and also: complex. We provide the vital insights for the right strategic and operational decisions.
Our healthcare experts are here to provide new perspectives and context analyses on the German healthcare market.
Whether you want to inspire your team, shed some light on developments in the healthcare market, or enrich your conference: We share our insights in conference keynotes and on panels, in contributions to the most significant healthcare, pharma, and medtech publications, as well as in client-internal ignite events.
Understanding trends, uncovering opportunities, anticipating and mitigating risks: Our market monitoring is your reliable companion: For strategic considerations, and your day-to-day operations.
The German healthcare market is highly active: Both from a competitive and a regulatory perspective. For many of our clients, our individual market monitoring is a reliable source of up-to-date, precise, and concise market insights: Be it to assess and competitive action, to remain compliant to German regulation, or to identify their next competitive edge.
When entering the German market, or (re)positioning your healthcare product, it is crucial to understand your competition.
There is a lot of activity in the German healthcare market: With a population of 83 million people, one of the best funded and most complex healthcare systems worldwide, and healthcare spendings of close to 500 billion Euro, Germany is one of the most attractive and strategically most important healthcare markets in the world. We make sure that you understand your competition to identify the best approach for your positioning and market access path.
Let’s get you up to speed with everything you really need to know: Our Bootcamp for the German healthcare market.
Especially if you have not been active in the German market before, it can be invaluable to get everyone on your team on the same page: Why is the German healthcare market attractive, special, and so complex? How is it structured? Which players are relevant for your product? We tailor our bootcamp specifically to your product and market challenges to provide a solid foundation for your next steps and decisions.
An attractive target market is only half the story. With a market-entry business case, we ensure that you are basing your market access plans on realistic assumptions and a sound business model.
Entering the German healthcare market or launching a new product comes with many particularities, which are hard to assess from outside: When will my field force start to be effective, how long will it take to get my DiGA reimbursed? Are we assuming realistic customer acquisition costs (CAC)? We challenge your business case for the German market – or create it from scratch.
Especially – but not only – for a reimbursement path, prescribers are important gate keepers: Our established Voice-of-Prescriber studies provide first-hand insights from these critical stakeholders.
The regulatory approval of a pharmaceutical or medtech product is just the beginning. The success of your prescription product in the German market will often strongly depend on prescribers, or HCPs in general. They need to be aware of your product innovation, repositioning, or existing product, understand and approve it, be convinced of the benefits, and prescribe or recommend it to patients. Medical professionals are one of the most valuable source of feedback to make your product more successful. Voice-of-Prescriber studies are qualitative, highly insightful first-hand studies: Where are the pain points in the decision making, prescription or consultation process? Which aspects are most important to prescribers? How should you adjust your product to better support HCPs, their processes, and therapies?
It is already an established best practice to include patients – or more generally customers and users during product development. But when it comes to market access or go-to-market decisions, the devil is in the details.
Similar to Voice-of-Prescriber studies, Voice-of-Patient studies are one of our most powerful, insightful, and most frequently used tools to support our clients with market-access and go-to-market decisions. In-person qualitative patient studies allow for a tailored assessment of your value proposition: How do patients or consumers perceive my product? Are we conveying the right messages in the right way? Have we set the right focus? Have we missed something?
Clients and Partners